Tyrosine

vascular endothelial growth factor A ; Homo sapiens







172 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 35451751 SH2-Domain Protein Isolation Using Synthetic Phosphorylated Peptides to Study VEGFR2 Signaling. 2022 1
2 34742690 PEDF is an endogenous inhibitor of VEGF-R2 angiogenesis signaling in endothelial cells. 2021 Dec 3
3 31698959 Is there truly an increase in risk of cardiovascular and hematological adverse events with vascular endothelial growth factor receptor tyrosine kinase inhibitors? 2020 Feb 1
4 31699213 Renal thrombotic microangiopathy during nintedanib treatment for idiopathic pulmonary fibrosis
. 2020 Jan 1
5 31935623 Recent advancements in the treatment of metastatic clear cell renal cell carcinoma: A review of the evidence using second-generation p-values. 2020 Jan 3 1
6 31948999 Targeting PD-1 or PD-L1 in Metastatic Kidney Cancer: Combination Therapy in the First-Line Setting. 2020 May 1 2
7 32541317 Medical treatment of advanced malignant perivascular epithelioid cell tumors. 2020 Jul 1
8 32931526 Visible light mediated PVA-tyramine hydrogels for covalent incorporation and tailorable release of functional growth factors. 2020 Sep 21 1
9 33182041 Isolation of anti-VEGF monoclonal antibodies with neutralizing effects from an Astragalus-induced immune antibody library. 2020 Nov 1
10 31270273 Retinol binding protein 3 is increased in the retina of patients with diabetes resistant to diabetic retinopathy. 2019 Jul 3 1
11 31479717 Cardiovascular benefits of tyrosol and its endogenous conversion into hydroxytyrosol in humans. A randomized, controlled trial. 2019 Nov 1 1
12 31545295 Angiopoietin-like 4 binds neuropilins and cooperates with VEGF to induce diabetic macular edema. 2019 Nov 1 1
13 31604823 No evidence of Gremlin1-mediated activation of VEGFR2 signaling in endothelial cells. 2019 Nov 29 1
14 31646776 Current and emerging first-line systemic therapies in metastatic clear-cell renal cell carcinoma. 2019 Jul-Aug 2
15 31751886 A systems biology approach to identify the key targets of curcumin and capsaicin that downregulate pro-inflammatory pathways in human monocytes. 2019 Dec 1
16 31844810 Soluble fms-Like Tyrosine Kinase 1 Localization in Renal Biopsies of CKD. 2019 Dec 2
17 31847469 Temporal Dynamics of VEGFA-Induced VEGFR2/FAK Co-Localization Depend on SHB. 2019 Dec 15 1
18 31956465 Exceptional Response of Metastatic Chromophobe Renal Cell Carcinoma to Vascular Endothelial Growth Factor (VEGF) Inhibitors: Should Increased VEGF-C Expression Be Used to Guide Treatment? 2019 1
19 29068796 Protein phosphatases and podocyte function. 2018 Jan 1
20 29455659 Receptor tyrosine kinases and downstream pathways as druggable targets for cancer treatment: the current arsenal of inhibitors. 2018 Feb 19 1
21 28252668 Aggretin Venom Polypeptide as a Novel Anti-angiogenesis Agent by Targeting Integrin alpha2beta1. 2017 Mar 2 2
22 28330784 Vascular endothelial growth factor (VEGF) and VEGF receptor inhibitors in the treatment of renal cell carcinomas. 2017 Jun 2
23 28424170 ROS-induced ROS release orchestrated by Nox4, Nox2, and mitochondria in VEGF signaling and angiogenesis. 2017 Jun 1 2
24 28507041 Publisher's Note - Relating to the retraction of: Oxidative stress inactivates VEGF survival signaling in retinal endothelial cells via PI 3-kinase tyrosine nitration. Azza B. El-Remessy, Manuela Bartoli, Danial H. Platt, David Fulton, Ruth B. Caldwell. J. Cell Sci. doi:10.1242/jcs.195966. 2017 May 15 1
25 27507763 Inhibition of VEGF165/VEGFR2-dependent signaling by LECT2 suppresses hepatocellular carcinoma angiogenesis. 2016 Aug 10 1
26 27528208 Oxidative stress inactivates VEGF survival signaling in retinal endothelial cells via PI 3-kinase tyrosine nitration. 2016 Aug 15 1
27 27662093 Evidence for Pro-angiogenic Functions of VEGF-Ax. 2016 Sep 22 1
28 27871478 Transendothelial migration of human umbilical mesenchymal stem cells across uterine endothelial monolayers: Junctional dynamics and putative mechanisms. 2016 Dec 3
29 24265228 Crosstalk between VEGF and MTA1 signaling pathways contribute to aggressiveness of breast carcinoma. 2015 May 1
30 25102966 VEGF Receptor 2 (VEGFR2) Activation Is Essential for Osteocyte Survival Induced by Mechanotransduction. 2015 Feb 2
31 25354586 Carbon monoxide inhibits sprouting angiogenesis and vascular endothelial growth factor receptor-2 phosphorylation. 2015 Feb 2
32 25893857 The Cell Adhesion Molecule Necl-4/CADM4 Serves as a Novel Regulator for Contact Inhibition of Cell Movement and Proliferation. 2015 1
33 26033246 Phosphorylation of Ser-279/282 and Tyr-265 positions on Cx43 as possible mediators of VEGF-165 inhibition of pregnancy-adapted Ca2+ burst function in ovine uterine artery endothelial cells. 2015 Sep 5 1
34 26051280 The tetrapeptide Arg-Leu-Tyr-Glu inhibits VEGF-induced angiogenesis. 2015 Aug 7 1
35 26067165 Site-Specific Phosphorylation of VEGFR2 Is Mediated by Receptor Trafficking: Insights from a Computational Model. 2015 Jun 2
36 26327764 Carvedilol may attenuate liver cirrhosis by inhibiting angiogenesis through the VEGF-Src-ERK signaling pathway. 2015 Aug 28 1
37 26413215 Impact of MET targeting on tumor-associated angiogenesis and growth of MET mutations-driven models of liver cancer. 2015 Jul 1
38 24508097 Increased placental angiogenesis in late and early onset pre-eclampsia is associated with differential activation of vascular endothelial growth factor receptor 2. 2014 Mar 1
39 24583284 Phosphorylation of DEP-1/PTPRJ on threonine 1318 regulates Src activation and endothelial cell permeability induced by vascular endothelial growth factor. 2014 Jun 1
40 22746102 A role for virally induced reactive oxygen species in Kaposi's sarcoma herpesvirus tumorigenesis. 2013 Jan 1 2
41 23086340 STAT1 activation by venous malformations mutant Tie2-R849W antagonizes VEGF-A-mediated angiogenic response partly via reduced bFGF production. 2013 Jan 1
42 23792958 Identification of PDCL3 as a novel chaperone protein involved in the generation of functional VEGF receptor 2. 2013 Aug 9 1
43 24358106 Evidence for post-translational processing of vascular endothelial (VE)-cadherin in brain tumors: towards a candidate biomarker. 2013 1
44 22062947 Activation of VEGFR-2 signaling in response to moderate dose of ultraviolet B promotes survival of normal human keratinocytes. 2012 Jan 1
45 22065111 Pleiotrophin is a potential colorectal cancer prognostic factor that promotes VEGF expression and induces angiogenesis in colorectal cancer. 2012 Mar 2
46 22763125 Tyrosine phosphatase PTP-MEG2 negatively regulates vascular endothelial growth factor receptor signaling and function in endothelial cells. 2012 Sep 1 2
47 23047550 Vascular endothelial growth factor signals through platelet-derived growth factor receptor β in meningiomas in vitro. 2012 Nov 6 2
48 21245381 Neuropilin-1 signaling through p130Cas tyrosine phosphorylation is essential for growth factor-dependent migration of glioma and endothelial cells. 2011 Mar 1
49 21636804 Thioredoxin-interacting protein mediates TRX1 translocation to the plasma membrane in response to tumor necrosis factor-α: a key mechanism for vascular endothelial growth factor receptor-2 transactivation by reactive oxygen species. 2011 Aug 1
50 22174934 Phosphorylation of Akt and ERK1/2 is required for VEGF-A/VEGFR2-induced proliferation and migration of lymphatic endothelium. 2011 1